Product Code: GVR-3-68038-300-3
Wound Care Market Growth & Trends:
The global wound care market is anticipated to reach USD 29.57 billion by 2030, growing at a CAGR of 4.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing number of surgical cases, a rapidly aging population, as well as a rising number of diabetic patients, are among the major factors driving this market's growth. For instance, according to Ageing Asia, as of 2019, more than 139 million people, i.e., about 10% of India's total population, were over 60. This is expected to increase up to 19.5% in 2050. The geriatric population is more susceptible to wounds, and thus, increasing the number of elder populations, the wound care market is anticipated to propel during the forecast period.
The wound care market has seen significant technological advancements in recent years, leading to the development of new and innovative products for treating various types of wounds. Growth factors are naturally occurring proteins that stimulate cell growth and division. These proteins can be used in wound care to promote healing and tissue regeneration. For example, platelet-derived growth factor (PDGF) is effective in promoting the healing of chronic wounds. 3D printing technology has revolutionized the production of custom-made wound care products, such as prosthetic limbs, orthotics, and wound dressings.
In addition, many leading manufacturers are undergoing strategic initiatives such as product launches, partnerships, and geographic expansion, which may help them capitalize on the increasing demand for wound care products during the forecast period. For instance, Human Biosciences planned on launching two new wound care products in the Indian market. The launch of these products in the Indian market is expected to help the company capture the post-pandemic wound care market in India. Thus, similar initiatives by other market players are anticipated to boost the wound care market post-pandemic.
Wound Care Market Report Highlights:
- Based on product, advanced wound dressing dominated the wound care market with a share of 34.9% in 2024, owing to the advantages offered by these dressings over traditional.
- Based on application, the chronic wound segment will likely dominate the wound care market with a market share of 59.9% in 2024, owing to increased diabetic foot ulcers and pressure ulcers worldwide.
- Based on end-use, the hospital segment dominated the wound care market, owing to the increasing number of surgical site infections among hospital patients. On the other hand, the home healthcare segment is anticipated to witness the fastest growth in the forecast period.
- Based on the mode of purchase, the prescribed segment dominated the wound care market, with a share of 62.8% in 2024.
- Based on the distribution channel, the institutional sales segment dominated the market. However, the retail sales segment is anticipated to witness the fastest growth, with a CAGR of 4.6% over the forecast period.
- North America dominated the wound care market with the highest revenue share of 45.5% in 2024 owing to the increasing number of surgical procedures and technological advancements.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Wound Care Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
- 3.2.1.2. Rising incidence of burn injuries
- 3.2.1.3. Introduction of innovative and advanced wound products
- 3.2.1.4. Rising geriatric population
- 3.2.1.5. Increasing number of road accidents and trauma injuries
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of advanced wound care products and chronic wound treatments
- 3.2.2.2. Delayed diagnosis and lower treatment rates in emerging nations
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Improvements in public and private hospital infrastructure
- 3.2.3.2. Growth potential in emerging economies in wound care market
- 3.2.3.3. Rising number of clinical trials
- 3.2.4. Market challenge analysis
- 3.2.4.1. Growing number of product recalls
- 3.2.4.2. Lack of awareness about proper wound care practices and available treatment options
- 3.3. Wound Care Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
Chapter 4. Wound Care Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Wound Care Market Movement Analysis
- 4.3. Global Wound Care Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Advanced wound dressing
- 4.4.1. Advanced wound dressing market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.2. Foam dressings
- 4.4.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.3. Hydrocolloid dressings
- 4.4.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.4. Film dressings
- 4.4.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.5. Alginate dressings
- 4.4.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.6. Hydrogel dressings
- 4.4.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.7. Collagen dressings
- 4.4.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.8. Other advanced dressings
- 4.4.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Surgical wound care
- 4.5.1. Surgical wound care market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Sutures & staples
- 4.5.2.1. Sutures & staples market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3. Tissue adhesives & sealants
- 4.5.3.1. Tissue adhesives & sealants market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.4. Anti-infective dressing
- 4.5.4.1. Anti-infective dressing market estimates and forecast 2018 to 2030 (USD Million)
- 4.6. Traditional wound care
- 4.6.1. Traditional wound care market estimates and forecast 2018 to 2030 (USD Million)
- 4.6.2. Medical tapes
- 4.6.2.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million)
- 4.6.3. Cotton
- 4.6.3.1. Cotton market estimates and forecast 2018 to 2030 (USD Million)
- 4.6.4. Bandages
- 4.6.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million)
- 4.6.5. Gauzes
- 4.6.5.1. Gauzes market estimates and forecast 2018 to 2030 (USD Million)
- 4.6.6. Sponges
- 4.6.6.1. Sponges market estimates and forecast 2018 to 2030 (USD Million)
- 4.6.7. Cleansing agents
- 4.6.7.1. Cleansing agents market estimates and forecast 2018 to 2030 (USD Million)
- 4.7. Wound therapy devices
- 4.7.1. Wound therapy devices market estimates and forecast 2018 to 2030s (USD Million)
- 4.7.2. Negative pressure wound therapy
- 4.7.2.1. Negative pressure wound therapy market estimates and forecast 2018 to 2030 (USD Million)
- 4.7.3. Oxygen and hyperbaric oxygen equipment
- 4.7.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 to 2030 (USD Million)
- 4.7.4. Electric stimulation devices
- 4.7.4.1. Electric stimulation devices market estimates and forecast 2018 to 2030 (USD Million)
- 4.7.5. Pressure relief devices
- 4.7.5.1. Pressure relief devices market estimates and forecast 2018 to 2030 (USD Million)
- 4.7.6. Others
- 4.7.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Wound Care Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Wound Care Market Movement Analysis
- 5.3. Global Wound Care Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Acute Wounds
- 5.4.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.2. Surgical & traumatic wounds
- 5.4.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.3. Burns
- 5.4.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Chronic Wounds
- 5.5.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Diabetic foot ulcers
- 5.5.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.3. Pressure ulcers
- 5.5.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.4. Venous leg ulcers
- 5.5.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.5. Others chronic wounds
- 5.5.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Wound Care Devices: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Wound Care Market Movement Analysis
- 6.3. Global Wound Care Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Specialty clinics
- 6.5.1. Specialty clinics centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.6. Home healthcare
- 6.6.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
- 6.7. Physician's office
- 6.7.1. Physician's office market estimates and forecast 2018 to 2030 (USD Million)
- 6.8. Nursing Homes
- 6.8.1. Nursing homes market estimates and forecast 2018 to 2030 (USD Million)
- 6.9. Others
- 6.9.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Wound Care Market: Mode of Purchase Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Wound Care Market Movement Analysis
- 7.3. Global Wound Care Market Size & Trend Analysis, by Mode Of Purchase, 2018 to 2030 (USD Million)
- 7.4. Prescribed
- 7.4.1. Prescribed market estimates and forecast 2018 to 2030 (USD Million)
- 7.5. Non-prescribed (OTC)
- 7.5.1. Non-prescribed (OTC) market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Wound Care Market: Distribution Channel Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Global Wound Care Market Movement Analysis
- 8.3. Global Wound Care Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
- 8.4. Institutional sales
- 8.4.1. Institutional sales market estimates and forecast 2018 to 2030 (USD Million)
- 8.5. Retail sales
- 8.5.1. Retail sales market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Wound Care Market: Regional Estimates & Trend Analysis
- 9.1. Regional Dashboard
- 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 9.3. North America
- 9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.3.2. U.S.
- 9.3.2.1. Key country dynamics
- 9.3.2.2. Competitive scenario
- 9.3.2.3. Regulatory framework
- 9.3.2.4. Reimbursement scenario
- 9.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 9.3.3. Canada
- 9.3.3.1. Key country dynamics
- 9.3.3.2. Competitive scenario
- 9.3.3.3. Regulatory framework
- 9.3.3.4. Reimbursement scenario
- 9.3.3.5. Canada market estimates and forecasts, 2018 - 2030
- 9.3.4. Mexico
- 9.3.4.1. Key country dynamics
- 9.3.4.2. Competitive scenario
- 9.3.4.3. Regulatory framework
- 9.3.4.4. Reimbursement scenario
- 9.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
- 9.4. Europe
- 9.4.1. UK
- 9.4.1.1. Key country dynamics
- 9.4.1.2. Competitive scenario
- 9.4.1.3. Regulatory framework
- 9.4.1.4. Reimbursement scenario
- 9.4.1.5. UK market estimates and forecasts, 2018 - 2030
- 9.4.2. Germany
- 9.4.2.1. Key country dynamics
- 9.4.2.2. Competitive scenario
- 9.4.2.3. Regulatory framework
- 9.4.2.4. Reimbursement scenario
- 9.4.2.5. Germany market estimates and forecasts, 2018 - 2030
- 9.4.3. France
- 9.4.3.1. Key country dynamics
- 9.4.3.2. Competitive scenario
- 9.4.3.3. Regulatory framework
- 9.4.3.4. Reimbursement scenario
- 9.4.3.5. France market estimates and forecasts, 2018 - 2030
- 9.4.4. Italy
- 9.4.4.1. Key country dynamics
- 9.4.4.2. Competitive scenario
- 9.4.4.3. Regulatory framework
- 9.4.4.4. Reimbursement scenario
- 9.4.4.5. Italy market estimates and forecasts, 2018 - 2030
- 9.4.5. Spain
- 9.4.5.1. Key country dynamics
- 9.4.5.2. Competitive scenario
- 9.4.5.3. Regulatory framework
- 9.4.5.4. Reimbursement scenario
- 9.4.5.5. Spain market estimates and forecasts, 2018 - 2030
- 9.4.6. Denmark
- 9.4.6.1. Key country dynamics
- 9.4.6.2. Competitive scenario
- 9.4.6.3. Regulatory framework
- 9.4.6.4. Reimbursement scenario
- 9.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 9.4.7. Sweden
- 9.4.7.1. Key country dynamics
- 9.4.7.2. Competitive scenario
- 9.4.7.3. Regulatory framework
- 9.4.7.4. Reimbursement scenario
- 9.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 9.4.8. Norway
- 9.4.8.1. Key country dynamics
- 9.4.8.2. Competitive scenario
- 9.4.8.3. Regulatory framework
- 9.4.8.4. Reimbursement scenario
- 9.4.8.5. Norway market estimates and forecasts, 2018 - 2030
- 9.5. Asia Pacific
- 9.5.1. Japan
- 9.5.1.1. Key country dynamics
- 9.5.1.2. Competitive scenario
- 9.5.1.3. Regulatory framework
- 9.5.1.4. Reimbursement scenario
- 9.5.1.5. Japan market estimates and forecasts, 2018 - 2030
- 9.5.2. India
- 9.5.2.1. Key country dynamics
- 9.5.2.2. Competitive scenario
- 9.5.2.3. Regulatory framework
- 9.5.2.4. Reimbursement scenario
- 9.5.2.5. India market estimates and forecasts, 2018 - 2030
- 9.5.3. China
- 9.5.3.1. Key country dynamics
- 9.5.3.2. Competitive scenario
- 9.5.3.3. Regulatory framework
- 9.5.3.4. Reimbursement scenario
- 9.5.3.5. China market estimates and forecasts, 2018 - 2030
- 9.5.4. South Korea
- 9.5.4.1. Key country dynamics
- 9.5.4.2. Competitive scenario
- 9.5.4.3. Regulatory framework
- 9.5.4.4. Reimbursement scenario
- 9.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 9.5.5. Australia
- 9.5.5.1. Key country dynamics
- 9.5.5.2. Competitive scenario
- 9.5.5.3. Regulatory framework
- 9.5.5.4. Reimbursement scenario
- 9.5.5.5. Australia market estimates and forecasts, 2018 - 2030
- 9.5.6. Thailand
- 9.5.6.1. Key country dynamics
- 9.5.6.2. Competitive scenario
- 9.5.6.3. Regulatory framework
- 9.5.6.4. Reimbursement scenario
- 9.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 9.6. Latin America
- 9.6.1. Brazil
- 9.6.1.1. Key country dynamics
- 9.6.1.2. Competitive scenario
- 9.6.1.3. Regulatory framework
- 9.6.1.4. Reimbursement scenario
- 9.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 9.6.2. Argentina
- 9.6.2.1. Key country dynamics
- 9.6.2.2. Competitive scenario
- 9.6.2.3. Regulatory framework
- 9.6.2.4. Reimbursement scenario
- 9.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
- 9.7. MEA
- 9.7.1. South Africa
- 9.7.1.1. Key country dynamics
- 9.7.1.2. Competitive scenario
- 9.7.1.3. Regulatory framework
- 9.7.1.4. Reimbursement scenario
- 9.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 9.7.2. Saudi Arabia
- 9.7.2.1. Key country dynamics
- 9.7.2.2. Competitive scenario
- 9.7.2.3. Regulatory framework
- 9.7.2.4. Reimbursement scenario
- 9.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 9.7.3. UAE
- 9.7.3.1. Key country dynamics
- 9.7.3.2. Competitive scenario
- 9.7.3.3. Regulatory framework
- 9.7.3.4. Reimbursement scenario
- 9.7.3.5. UAE market estimates and forecasts, 2018 - 2030
- 9.7.4. Kuwait
- 9.7.4.1. Key country dynamics
- 9.7.4.2. Competitive scenario
- 9.7.4.3. Regulatory framework
- 9.7.4.4. Reimbursement scenario
- 9.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.2. Key Company Profiles
- 10.2.1. Smith+Nephew
- 10.2.1.1. Company overview
- 10.2.1.2. Financial performance
- 10.2.1.3. Product benchmarking
- 10.2.1.4. Strategic initiatives
- 10.2.2. Convatec Group PLC,
- 10.2.2.1. Company overview
- 10.2.2.2. Financial performance
- 10.2.2.3. Product benchmarking
- 10.2.2.4. Strategic initiatives
- 10.2.3. Molnlycke Health Care AB
- 10.2.3.1. Company overview
- 10.2.3.2. Financial performance
- 10.2.3.3. Product benchmarking
- 10.2.3.4. Strategic initiatives
- 10.2.4. Baxter
- 10.2.4.1. Company overview
- 10.2.4.2. Financial performance
- 10.2.4.3. Product benchmarking
- 10.2.4.4. Strategic initiatives
- 10.2.5. DeRoyal Industries, Inc
- 10.2.5.1. Company overview
- 10.2.5.2. Financial performance
- 10.2.5.3. Product benchmarking
- 10.2.5.4. Strategic initiatives
- 10.2.6. Coloplast Corp.
- 10.2.6.1. Company overview
- 10.2.6.2. Financial performance
- 10.2.6.3. Product benchmarking
- 10.2.6.4. Strategic initiatives
- 10.2.7. Medtronic
- 10.2.7.1. Company overview
- 10.2.7.2. Financial performance
- 10.2.7.3. Product benchmarking
- 10.2.7.4. Strategic initiatives
- 10.2.8. 3M
- 10.2.8.1. Company overview
- 10.2.8.2. Financial performance
- 10.2.8.3. Product benchmarking
- 10.2.8.4. Strategic initiatives
- 10.2.9. INTEGRA LIFESCIENCES
- 10.2.9.1. Company overview
- 10.2.9.2. Financial performance
- 10.2.9.3. Product benchmarking
- 10.2.9.4. Strategic initiatives
- 10.2.10. Medline Industries, LP
- 10.2.10.1. Company overview
- 10.2.10.2. Financial performance
- 10.2.10.3. Product benchmarking
- 10.2.10.4. Strategic initiatives
- 10.2.11. Johnson & Johnson Services, Inc.
- 10.2.11.1. Company overview
- 10.2.11.2. Financial performance
- 10.2.11.3. Product benchmarking
- 10.2.11.4. Strategic initiatives
- 10.2.12. B. Braun SE
- 10.2.12.1. Company overview
- 10.2.12.2. Financial performance
- 10.2.12.3. Product benchmarking
- 10.2.12.4. Strategic initiatives
- 10.2.13. Cardinal Health
- 10.2.13.1. Company overview
- 10.2.13.2. Financial performance
- 10.2.13.3. Product benchmarking
- 10.2.13.4. Strategic initiatives
- 10.2.14. Organogenesis Inc
- 10.2.14.1. Company overview
- 10.2.14.2. Financial performance
- 10.2.14.3. Product benchmarking
- 10.2.14.4. Strategic initiatives
- 10.2.15. MIMEDX Group, Inc.
- 10.2.15.1. Company overview
- 10.2.15.2. Financial performance
- 10.2.15.3. Product benchmarking
- 10.2.15.4. Strategic initiatives
- 10.3. Heat Map Analysis/ Company Market Position Analysis
- 10.4. Estimated Company Market Share Analysis, 2024
- 10.5. List of Other Key Market Players